Skip to content

Clinical trials

Terminated Phase 2 Hemoglobinopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Phase: Phase 2 Status: Terminated Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20091
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine2
Craig Seaman1
National Institute of Allergy and Infectious Diseases (NIAID)1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies5
Anemia, Sickle Cell4
Thalassemia3
Acute Chest Syndrome1
Anemia, Hemolytic1
Bone Marrow Failure Disorders1
Hemoglobin SC Disease1
Immunologic Deficiency Syndromes1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid, Acute1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.